Natco Pharma share news, announcements and annual reports
NSE: NATCOPHARMBSE: 524816Pharmaceuticals & BiotechnologySmall Cap
Natco Pharma Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1995 on BSE, Dec 1995 on NSE
Last close ₹785.75up ₹3.35 (0.43%)BSE ₹786.05
Share price at the NSE close on 2 Nov 2026. Previous close ₹782.40.
2 Nov: open ₹790.05, high ₹791.75, low ₹780.95
52-week range of traded prices to 2 Nov 2026
₹773.60Low, 22 Oct 2026₹1,226.80High, 12 May 2026
- Next results date: the board meets on 13 Nov 2026 to consider: financial results and dividend. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15,414 Cr380th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 13.47
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.57%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.08
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,00,99056.3% delivered
Natco Pharma share news and announcements
1,035 announcements, routine notices left out, newest first. Page 14 of 21.
Feb 2015
11 Feb · Corporate action
Company has fixed Record Date as February 25, 2015 for the purpose of payment of interim dividend.11 Feb · Dividend
11 Feb · Dividend
Board of Directors at their meeting held on February 11, 2015, recommended payment of an interim dividend of Rs. 5/- per equity share of Rs. 10/- each for the year 2014-2015.
Jan 2015
30 Jan · Board meeting
To consider among other things, the unaudited financial Results for the quarter ended December 31, 2014, to consider Interim Dividend, if any, for the financial year 2014-15 and related matters etc.21 Jan · Business
Dec 2014
17 Dec · Legal
Exchange has sought clarification from Natco Pharma Limited with respect to an announcement submitted to the Exchange dated December 16, 2014 informing that the committee of Directors at a meeting held on December 16, 2014 allotted 1,61,775 equity shares of Rs.10/- each at a premium of Rs.1190/- per share on preferential basis other than cash to the promoters of Natco Organics Limited. On basis of above the Company is required to clarify following: i. Issue period; ii. Names of the investors and of these, which are promoters or promoter group entities, iii. Post allotment of securities: - outcome of the subscription, number of investors. The response of the Company is awaited.12 Dec · Business
Nov 2014
27 Nov · Updates
Exchange has sought clarification from Natco Pharma Limited with respect to a press release dated November 27, 2014 regarding the settlement of the legal dispute with SMS Pharmaceuticals Limited. In this regard, the Exchange has advised the Company to provide clarification/confirmation with respect to the following: (1) Brief details of litigation viz. name(s) of the court/tribunal/agency where litigation is filed, brief details of dispute/litigation. The response from the Company is awaited.27 Nov · Business
13 Nov · Board meeting
Board of Directors at their meeting held on November 12, 2014, taken on record the following: 1. Mr. P.S.R.K. Prasad, Executive Vice President (Corporate Engineering Services) appointed as Additional Director of the Company who will be in the wholetime employment of the Company. 2. Mr. S.V.V.N. Appa Rao, Vice President (Finance & Accounts) appointed as Interim (Chief Financial Officer) of the Company.
Oct 2014
31 Oct · Board meeting
To consider among other things, the un-audited financial Results for the quarter ended September 30, 2014 and related matters.22 Oct · Demise
Dr. P. Bhaskara Narayana, Director and Chief Financial Officer of the Company passed away on October 21, 2014.10 Oct · Disclosure of Voting Pattern - Clause 35A
Sep 2014
29 Sep · Disclosure of Voting Pattern - Clause 35A
Aug 2014
13 Aug · Board meeting
13 Aug · Meeting
Register of Members and Share Transfer Books of the Company will remain closed from September 24, 2014 to September 27, 2014 (both days inclusive) for the purpose of Annual General Meeting of the Company to be held on September 27, 2014.
Jul 2014
Jun 2014
May 2014
20 May · Updates
Trading Window for dealing in the securities of the company will be closed from May 20, 2014 to May 31, 2014 (both days inclusive). Trading window will be opened from June 02, 2014.
Apr 2014